Shijiazhuang Sihua Pharmaceutical Obtains Drug Production Registration Approval for Rosuvastatin Calcium Tablets


发布时间:2020-08-20

【概要描述】 Recently, Shijiazhuang Sihua Pharmaceutical Co., Ltd. obtained a drug registration certificate from the National Medical Products Administration for rosuvastatin calcium tablets (10 mg).

 

Recently, Shijiazhuang Sihua Pharmaceutical Co., Ltd. obtained a drug registration certificate from the National Medical Products Administration for rosuvastatin calcium tablets (10 mg).
Shijiazhuang Sihua Pharmaceutical’s rosuvastatin calcium tablets (10 mg) were submitted under Category 4 of the Chemical Drug Registration Classification and, upon approval, are deemed to have passed the consistency evaluation.
According to available information, rosuvastatin calcium tablets are primarily used for the treatment of primary hypercholesterolemia or mixed dyslipidemia.

 

Keywords: